🇺🇸 FDA

Intelligence · Patent portfolio

PTC THERAPEUTICS Patents

Full USPTO pharma patent portfolio for PTC THERAPEUTICS — grant dates, expiration, and drug cross-links.

Patents
149
Expiring ≤24m
3

Quick answer

PTC THERAPEUTICS has 149 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months — use filters for patent-cliff planning.

Page 3 of 4

  1. US 8932818

    Screening assays for compounds that modulate programmed ribosomal frameshifting

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8927576

    HCV inhibitor and therapeutic agent combinations

    Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8841302

    HCV inhibitor and therapeutic agent combinations

    Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8796322

    Methods for using 1,2,4-oxadiazole benzoic acid compounds

    Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8748625

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid

    Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8735414

    Indole derivatives and methods for antiviral treatment

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8716321

    Methods for dosing an orally active 1,2,4-oxadiazole

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8710031

    Compounds for nonsense suppression and methods for their use

    Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8703726

    Methods for treating prostate conditions

    Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8697662

    Methods for treating Kaposi sarcoma

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8691511

    Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and their use in bioassays

    Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8680113

    BMI-1 protein expression modulators

    Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8633019

    Methods for treating spinal muscular atrophy

    Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8486982

    1,2,4-oxadiazole benzoic acids

    Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8460864

    Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same

    Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8394966

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid

    Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8372860

    Carboline derivatives useful in the inhibition of angiogenesis

    Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8367694

    Carboline derivatives useful in the inhibition of angiogenesis

    Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8367841

    Processes for the preparation of 1,2,4-oxadiazole benzoic acids

    Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8334313

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8299105

    1,2,4-oxadiazole benzoic acid compositions and their use in bioassays

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8278085

    RNA processing protein complexes and uses thereof

    Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8227494

    Pharmaceutical compositions of 1,2,4-oxadiazole benzoic acid and their use for the treatment of disease

    Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8163782

    1,2,4-oxadiazole benzoic acid compositions

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8143257

    Substituted phenols as active agents inhibiting VEGF production

    Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8129540

    Methods for the synthesis of 1,2,4-oxadiazole benzoic acid compounds

    Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8101641

    Hydroxylated 1,2,4-oxadiazole benzoic acid compounds and compositions thereof

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8076352

    Administration of carboline derivatives useful in the treatment of cancer and other diseases

    Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8076353

    Inhibition of VEGF translation

    Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8017636

    1,2,4-Oxadiazole benzoic acid compositions and their use in bioassays

    Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8013006

    Methods for treating hepatitis C

    Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7973069

    Methods for treating hepatitis C

    Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7939468

    Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-proliferative agents

    Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7902241

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7902235

    Compounds for nonsense suppression, and methods for their use

    Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7863456

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-YL]-benzoic acid

    Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7829503

    Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-fungal agents

    Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7781478

    Methods for treating hepatitis C

    Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7772271

    Methods for treating hepatitis C

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7772259

    1,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7767689

    Carboline derivatives useful in the treatment of cancer

    Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7683082

    1,2,4-oxadiazole benzoic acid compositions and their use in bioassays

    Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7678922

    Processes for the preparation of 1,2,4-oxadiazole benzoic acids

    Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7645881

    Methods for treating hepatitis C

    Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7601840

    Carboline derivatives useful in the inhibition of angiogenesis

    Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7449570

    Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases

    Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7419991

    3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, compositions, and methods for the use thereof

    Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7405233

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does PTC THERAPEUTICS have?

149 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do PTC THERAPEUTICS patents expire?

3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.